Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

Cancer statistics, 1999

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text

Medicine, Biostatistics, Oncology +17

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

Toshihiro Mineta, Samuel D. Rabkin, Takahito Yazaki et al. · Nature Medicine · 1995 · 824 citations

Medicine, Biomedical Sciences, Oncology +12

The γ ₁ 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase

Bin He, Martin Gross, Bernard Roizman · Proceedings of the National Academy of Sciences · 1997 · 749 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Mapping of Herpes Simplex Virus-1 Neurovirulence to γ ₁ 34.5, a Gene Nonessential for Growth in Culture

J Chou, Earl R. Kern, Richard J. Whitley et al. · Science · 1990 · 711 citations

Life Sciences, Genetics, Molecular Biology +9

Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

David Z. J. Chu, Nicholas P. Lang, C Thompson et al. · Cancer · 1989 · 597 citations · Full text

Medicine, Oncology, Surgery +17